{"index": {"_index": "jga-study", "_id": "JGAS000351"}}
{"properties": {"alias": "JSUB000519_Study_0001", "center_name": "Individual", "accession": "JGAS000351", "DESCRIPTOR": {"STUDY_TITLE": "Amplicon sequencing of melanoma samples", "STUDY_TYPES": {"STUDY_TYPE": {"existing_study_type": "Tumor vs. Matched-Normal"}}, "STUDY_ABSTRACT": "The types of biomarkers for skin tumors have been 1) biochemical markers in blood, urine, and body fluid, 2) \nhistopathological markers, 3) genetic examination of tumor tissue, 4) tumor-susceptibility assessed by germ_x0002_line genetic examination. Biomarkers in a blood are frequently used in the treatment of cutaneous \nmalignancies, but are not suitable for early detection of malignancies. Research on circulating tumor cells, cell \nfree DNA, exosomes has been promoted in recent years, but clinical application is halfway. Based on these \ncircumstances, the purpose of this study is to search for biomarkers for diagnosis, therapeutic effect, and \nfollow-up of skin tumors, and to verify their usefulness."}, "STUDY_ATTRIBUTES": {"STUDY_ATTRIBUTE": [{"TAG": "NBDC Number", "VALUE": "hum0295"}, {"TAG": "Registration date", "VALUE": "2021-10-04"}, {"TAG": "Submitting organization", "VALUE": "Sapporo Medical University"}, {"TAG": "Principal Investigator", "VALUE": "Hisashi Uhara"}, {"TAG": "Molecular Data Type", "VALUE": "Amplicon sequencing"}, {"TAG": "Platform", "VALUE": "Ion S5"}, {"TAG": "Vendor", "VALUE": "Thermo"}, {"TAG": "Comment", "VALUE": null}, {"TAG": "Primary Phenotype", "VALUE": "Melanoma"}, {"TAG": "Phenotype", "VALUE": "Sebaceous nevus"}, {"TAG": "Phenotype", "VALUE": "Trichoblastoma"}, {"TAG": "Phenotype", "VALUE": "Poroma"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C21.0"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C51.1"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C43.4"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C43.5"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C43.6"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "C43.7"}, {"TAG": "ICD-10 Disease Classification", "VALUE": "D23.7"}]}}, "identifier": "JGAS000351", "title": "Amplicon sequencing of melanoma samples", "description": "The types of biomarkers for skin tumors have been 1) biochemical markers in blood, urine, and body fluid, 2) \nhistopathological markers, 3) genetic examination of tumor tissue, 4) tumor-susceptibility assessed by germ_x0002_line genetic examination. Biomarkers in a blood are frequently used in the treatment of cutaneous \nmalignancies, but are not suitable for early detection of malignancies. Research on circulating tumor cells, cell \nfree DNA, exosomes has been promoted in recent years, but clinical application is halfway. Based on these \ncircumstances, the purpose of this study is to search for biomarkers for diagnosis, therapeutic effect, and \nfollow-up of skin tumors, and to verify their usefulness.", "name": "JSUB000519_Study_0001", "type": "jga-study", "url": "https://ddbj.nig.ac.jp/resource/jga-study/JGAS000351", "sameAs": null, "isPartOf": "jga", "organism": {"identifier": 9606, "name": "Homo sapiens"}, "dbXrefs": [{"identifier": "JGAP000001", "type": "jga-policy", "url": "https://ddbj.nig.ac.jp/resource/jga-policy/JGAP000001"}, {"identifier": "JGAC000001", "type": "jga-dac", "url": "https://ddbj.nig.ac.jp/resource/jga-dac/JGAC000001"}, {"identifier": "JGAD000465", "type": "jga-dataset", "url": "https://ddbj.nig.ac.jp/resource/jga-dataset/JGAD000465"}], "status": "public", "visibility": "unrestricted-access", "dateCreated": "2021-10-04T14:45:51+09:00", "dateModified": "2021-10-05T11:05:59+09:00", "datePublished": "2024-11-05T15:25:53+09:00"}
